Untreated interstitial cystitis (IC) doesn’t stay the same. Over time, chronic inflammation can permanently reshape the bladder wall, rewire how your nervous system processes pain, and erode nearly every dimension of daily life, from sleep to work to mental health. About half of all IC patients already show signs of bladder scarring, and without intervention, the condition tends to become harder to treat rather than easier to ignore.
Scarring and Shrinking of the Bladder
The most direct physical consequence of unmanaged IC is fibrosis, the gradual replacement of normal bladder tissue with stiff scar tissue. When the bladder’s protective lining stays damaged, urine essentially seeps into the bladder wall and triggers ongoing inflammation. Cells called fibroblasts respond by depositing collagen, thickening the wall and reducing its ability to stretch. Roughly 50% of IC patients show evidence of this scarring process.
The practical result is a bladder that holds less and less. A normal bladder can expand to about 1,000 cc under anesthesia. In later-stage IC, capacity can drop to 450 cc or below, meaning you feel urgently full with far less urine. Patients with severe fibrosis report significantly higher urinary frequency and reduced capacity compared to those with mild or moderate scarring. This is a one-direction change: once the tissue scars, it doesn’t return to normal on its own.
Fibrosis is also the main reason some patients stop responding to standard treatments. Behavioral changes, dietary modifications, and common medications work best on bladders that still have functional tissue to heal. When scarring becomes extensive, those first-line approaches lose effectiveness, and more intensive interventions become necessary.
Your Nervous System Learns to Amplify Pain
One of the less visible but most significant consequences of untreated IC is what happens in the spinal cord and brain. Persistent bladder irritation sends a constant stream of pain signals through the nerves, and over time, the nervous system adapts by lowering its threshold for what counts as painful. This process, called central sensitization, means that stimuli that wouldn’t normally hurt (a partially full bladder, light pressure on the pelvis) begin triggering pain.
The mechanism starts locally. Inflammation in the bladder causes a rise in nerve growth factor, a chemical that strengthens and multiplies the nerve connections carrying pain signals to the spinal cord. With enough repetition, the spinal cord neurons themselves become hyperexcitable. Studies on IC patients show a significantly heightened pain response to mechanical pressure compared to healthy individuals, with the pattern pointing to sensitization at the spinal level.
This matters because once the nervous system has been “retrained” to amplify pain, the problem is no longer just in the bladder. Even if bladder inflammation improves later, the pain can persist because the central nervous system has developed its own independent pain signaling. Researchers describe this as “permanent inflammatory imprinting” in both the bladder and the central nervous system, and it’s one reason early treatment produces better long-term outcomes than waiting.
Pelvic Floor Muscles Tighten in Response
Chronic bladder pain creates a chain reaction in the surrounding muscles. The pelvic floor, a hammock of muscles supporting the bladder, uterus, and rectum, reflexively tightens in response to ongoing pain. Over time, this becomes a sustained state of hypertonicity, where the muscles are chronically shortened and contracted rather than relaxed.
Imaging studies confirm that IC patients have significantly shorter pelvic floor muscles than healthy controls. This tightening doesn’t just worsen bladder symptoms. It can cause pain during sex, bowel dysfunction, and a broader chronic pelvic pain that extends well beyond the bladder itself. One specialist estimated that in 75% of patients referred for IC, the primary symptom driver turns out to be neuromuscular, originating in the pelvic floor. When pelvic floor dysfunction is addressed through physical therapy, bladder urgency, frequency, and bowel symptoms often improve together.
Left alone, this muscular guarding becomes self-reinforcing. Pain causes tightening, tightening causes more pain, and the cycle deepens. Trigger points develop in the muscles that can refer pain to the urethra, lower abdomen, and inner thighs, making the condition feel like it’s spreading.
Sleep Loss Compounds Everything
Nighttime urination is one of the most disruptive features of unmanaged IC. Up to 87% of IC patients experience nocturia, and in one large study, 62% reported waking at least twice per night, with 21% waking four or more times. At their worst, patients in that study reported a median of 8 nighttime episodes.
The damage isn’t just about lost hours. Waking during the first half of the night, when the deepest and most restorative sleep occurs, has the greatest negative impact on daytime functioning. Chronic sleep fragmentation from IC increases the risk of workplace accidents, impairs concentration, worsens mood, and compounds the fatigue that many patients already experience from pain alone. Pain itself and the depression that often accompanies IC also independently disrupt sleep, creating overlapping causes of exhaustion that become difficult to untangle.
Depression, Anxiety, and Panic
The psychological toll of untreated IC is not a secondary footnote. In a population-based study of women with IC, over one-third met criteria for a probable diagnosis of depression, and 52% reported recent panic attacks. These are strikingly high rates, far exceeding what you’d see in the general population.
This isn’t simply a matter of “feeling down” about a health condition. Chronic pain physically alters brain chemistry and stress-response systems. Sleep deprivation accelerates those changes. Social isolation, which IC often causes due to the constant need for bathroom access and the unpredictability of flares, removes the buffers that normally protect mental health. The combination creates a feedback loop: depression lowers pain tolerance, increased pain worsens depression, and both make it harder to pursue treatment.
Overlapping Conditions Tend to Cluster
IC rarely stays isolated. Compared to the general population, people with IC are 100 times more likely to have inflammatory bowel disease and 30 times more likely to have systemic lupus erythematosus. Irritable bowel syndrome, fibromyalgia, allergies, and sensitive skin also show significantly elevated rates in IC patients.
The exact reason for this clustering isn’t fully understood, but the leading theory involves shared mechanisms of immune dysfunction and central sensitization. When the nervous system becomes hypersensitive to pain signals from the bladder, it can also amplify signals from the gut, muscles, and skin. Whether untreated IC directly causes these conditions or whether they share a common underlying driver, the practical reality is the same: allowing IC to progress without management increases your overall burden of chronic symptoms.
Work, Income, and Daily Functioning
The effects of unmanaged IC extend into professional and financial life. Research from the RAND Corporation found that greater IC symptom impact predicted a higher likelihood of not working, more days kept from work by pain, and a leveling off of long-term earnings. Interestingly, it was the functional impact of symptoms (how much they interfered with activities) rather than raw symptom severity that predicted economic outcomes. Depression and the accumulation of additional health conditions independently made work participation worse.
This distinction matters. Two people with the same level of bladder pain can have very different functional outcomes depending on whether their sleep, mental health, and pelvic floor are also deteriorating. Untreated IC tends to pull all of these down together, compounding the effect on daily life in ways that severity scores alone don’t capture.
Hunner’s Lesions and Later-Stage Changes
Hunner’s lesions are inflamed, ulcer-like patches on the bladder wall that represent a distinct and more severe subtype of IC. Their prevalence increases sharply with age. In one major study, Hunner’s lesions appeared on cystoscopy in just 4% of patients under 50, but in 19.7% of those between 50 and 70, and 54.5% of those over 70. Another study found similar patterns, with rates climbing from about 9% in patients under 30 to over 55% in those older than 60.
Current evidence doesn’t confirm that skipping treatment directly causes Hunner’s lesions to develop. But their strong association with age and advancing disease suggests that longer duration of illness correlates with more severe bladder pathology. Patients with Hunner’s lesions typically have worse pain, smaller bladder capacity, and a more difficult treatment course than those without them.